Ocelus Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ocelus Ltd. - overview
Established
2007
Location
Newport, -, UK
Primary Industry
Pharmaceuticals
About
Ocelus Ltd. is a technological solutions provider that enhances operational capabilities and user experience through innovative software, aimed at various sectors including businesses of all sizes. Founded in 2007, Ocelus Ltd. is headquartered in Newport, UK.
The company specializes in developing advanced software solutions that streamline operations. It has successfully completed 3 deals to date. The latest funding round was a Series B, raising GBP 0. 310 mn from the Development Bank of Wales, bringing the total amount raised to GBP 0.
310 mn and current company valuation to GBP 1. 259 mn. Ocelus Ltd. delivers an advanced software platform that integrates data analytics, real-time monitoring, and automated reporting tools, focusing on enhancing operational efficiencies.
Targeting a wide range of clients from multinational corporations to SMEs, the platform, launched in 2021, addresses critical challenges in data management and operational visibility, particularly in North America, Western Europe, and parts of Asia. The company's revenue model is subscription-based, allowing clients to utilize the software platform with various tailored pricing tiers. Transactions occur through B2B partnerships, leading to contractual agreements that define service levels and pricing according to usage. Their flagship products include proprietary analytics tools and customizable dashboards, typically offered via annual subscriptions that ensure clients receive continuous updates and support, forming a stable financial foundation for the company's growth.
Ocelus Ltd. is focused on launching new products designed to enhance its software platform. Plans include expanding into additional geographic markets, particularly targeting regions in Asia and Europe by the end of 2024. The recent funding from the Series B round will facilitate these initiatives as well as ongoing innovation efforts.
Current Investors
Development Bank of Wales
Primary Industry
Pharmaceuticals
Sub Industries
Biotechnology, Pharmaceutical Research & Development
Website
www.ocelus.net
Company Stage
Ceased Operations
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.